Clinical Trial Update: ProQuad® Intramuscular vs Subcutaneous [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ProQuad intramuscular vs subcutaneous administration in measles/mumps rubella/varicella indications; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• ProQuad (Measles, Mumps, Rubella and Varicella live attenuated vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Measles, Mumps | Phase 3 | Status: COMPLETED | Results posted: 2018-08-13